We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

47 hedge funds and large institutions have $45M invested in ALPS Medical Breakthroughs ETF in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

222% more call options, than puts

Call options by funds: $832K | Put options by funds: $258K

5.68% more ownership

Funds ownership: 24.65%30.34% (+5.7%)

8% less funds holding

Funds holding: 5147 (-4)

15% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 13

19% less capital invested

Capital invested by funds: $55.2M → $45M (-$10.2M)

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

Holders
47
Holders Change
-4
Holders Change %
-7.84%
% of All Funds
1.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
9
Reduced
16
Closed
13
Calls
$832K
Puts
$258K
Net Calls
+$574K
Net Calls Change
-$3.19M

SBIO Hedge Fund Activity: Q1 2020 in Review

47 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2020, worth a combined $45M — down 19% from $55.2M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of SBIO and 11 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.64M. The largest seller was Cardan Capital Partners, cutting an estimated $1.01M.

  • 47 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2020, down from 51 in Q4 2019.
  • Funds reported $45M of ALPS Medical Breakthroughs ETF stock for Q1 2020, down 19% quarter-over-quarter.
  • 11 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2020 and 13 closed out, a net change of -2 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q1 2020 was Susquehanna International Group, an estimated $3.64M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q1 2020 was Cardan Capital Partners, an estimated $1.01M sold.

Based on aggregated 13F filings for Q1 2020.